Search hospitals > New Mexico > Albuquerque

Albuquerque Clinical Trials, Inc.

Claim this profile
Albuquerque, New Mexico 87102
Global Leader in Migraine
Global Leader in Arthritis
Conducts research for Juvenile Idiopathic Arthritis
Conducts research for Rheumatoid Arthritis
Conducts research for Osteoarthritis
119 reported clinical trials
4 medical researchers
Photo of Albuquerque Clinical Trials, Inc. in AlbuquerquePhoto of Albuquerque Clinical Trials, Inc. in Albuquerque

Summary

Albuquerque Clinical Trials, Inc. is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Migraine, Arthritis, Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Osteoarthritis and other specialties. Albuquerque Clinical Trials, Inc. is involved with conducting 119 clinical trials across 91 conditions. There are 4 research doctors associated with this hospital, such as Satkirin K Khalsa, Marigene Sharma, MD, Marigene Salazar Sharma, and Kim, Ellen.

Area of expertise

1Migraine
Global Leader
Albuquerque Clinical Trials, Inc. has run 34 trials for Migraine.
2Arthritis
Global Leader
Albuquerque Clinical Trials, Inc. has run 20 trials for Arthritis. Some of their research focus areas include:
Rheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive

Top PIs

Clinical Trials running at Albuquerque Clinical Trials, Inc.

Migraine
Osteoarthritis
Type 2 Diabetes
Knee Arthritis
Irritable Bowel Syndrome
Image of trial facility.

Ubrogepant

for Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 450 adult female participants with menstrual migraine will be enrolled in approximately 85 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 33 criteria
Image of trial facility.

Elismetrep

for Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatment of moderate or severe migraine.
Recruiting0 awards Phase 23 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Albuquerque Clinical Trials, Inc.?
Albuquerque Clinical Trials, Inc. is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Migraine, Arthritis, Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Osteoarthritis and other specialties. Albuquerque Clinical Trials, Inc. is involved with conducting 119 clinical trials across 91 conditions. There are 4 research doctors associated with this hospital, such as Satkirin K Khalsa, Marigene Sharma, MD, Marigene Salazar Sharma, and Kim, Ellen.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security